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Summary 
Objective. Pro-inflammatory cytokines play an important role in osteoarthritis (OA). In osteoarthritic cartilage, 
chondrocytes exhibit an alteration in mitochondrial activity. This study analyzes the effect of tumor necrosis factor-α 
(TNFα) and interleukin-1β (IL-1β) on the mitochondrial activity of normal human chondrocytes. 
Materials and methods. Mitochondrial function was evaluated by analyzing the activities of respiratory chain enzyme 
complexes and citrate synthase, as well as by mitochondrial membrane potential (Δψm) and adenosine triphosphate 
(ATP) synthesis. Bcl-2 family mRNA expression and protein synthesis were analyzed by RNase protection assay 
(RPA) and Western-blot, respectively. Cell viability was analyzed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide (MTT) and apoptosis by 4′, 6-diamidino-2-phenylindole dihydrochloride (DAPI) stain. 
Glycosaminoglycans were quantified in supernatant by a dimethyl-methylene blue binding assay. 
Results. Compared to basal cells, stimulation with TNFα (10 ng/ml) and IL-1β (5 ng/ml) for 48 h significantly 
decreased the activity of complex I (TNFα = 35% and IL-1β = 35%) and the production of ATP (TNFα = 18% and 
IL-1β = 19%). Both TNFα and IL-1β caused a definitive time-dependent decrease in the red/green fluorescence ratio 
in chondrocytes, indicating depolarization of the mitochondria. Both cytokines induced mRNA expression and 
protein synthesis of the Bcl-2 family. Rotenone, an inhibitor of complex I, caused a significant reduction of the 
red/green ratio, but it did not reduce the viability of the chondrocytes. Rotenone also increased Bcl-2 mRNA 
expression and protein synthesis. Finally, rotenone as well as TNFα and IL-1β, reduced the content of proteoglycans 
in the extracellular matrix of normal cartilage. 
Conclusion. These results show that both TNFα and IL-1β regulate mitochondrial function in human articular 
chondrocytes. Furthermore, the inhibition of complex I by both cytokines could play a key role in cartilage 
degradation induced by TNFα and IL-1β. These data could be important for understanding of the OA pathogenesis. 
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Introduction 
Osteoarthritis (OA) is the most common age-related cartilage and joint pathology. OA is a slowly 
progressive degenerative disease characterized by degradation of the matrix and cell death resulting in a 
gradual loss of articular cartilage integrity
1,2
. The chondrocyte, which is the only cell type present in 
mature cartilage, is responsible for repairing the damage tissue. Several cytokines may participate in the 
pathogenesis of cartilage damage by modifying the behavior of chondrocytes. In particular, interleukin-1β 
(IL-1β) and tumor necrosis factor-α (TNFα) are two of the principal cytokines linked to cartilage 
destruction
3,4,5
. However, the exact mechanism by which enhanced cytokine production in the cartilage 
modulates cartilage degradation remains unclear. 
 
Mitochondria are complex organelles that oxidize a wide range of metabolic intermediates. Multi-
enzyme complexes located both in the inner mitochondrial membrane and in the mitochondrial matrix 
oxidize tricarboxylic acid-cycle intermediates derived from primary nutrients
6
. The respiratory chain, 
located in the inner mitochondrial membrane, consists of five multimeric protein complexes: reduced 
nicotinamide adenine dinucleotide (NADH) dehydrogenase–ubiquinone oxidoreductase (complex I), 
succinate dehydrogenase (SDH)–ubiquinone oxidoreductase (complex II), ubiquinone–cytochrome c 
oxidoreductase (complex III), cytochrome c oxidase (complex IV), and adenosine triphosphate (ATP) 
synthase (complex V). The respiratory chain also requires two small electron carriers, ubiquinone 
(coenzyme Q10) and cytochrome c
6,7
. In mitochondrial oxidative phosphorylation, electron transport is 
coupled by the four enzyme complexes (I–IV) in the mitochondrial inner membrane with ATP synthesis 
from adenosine diphosphate (ADP) by complex V. The movement of electrons between the first four 
complexes of the chain produces a proton gradient across the inner mitochondrial membrane, which is 
one of the factors employed by complex V to generate ATP. Mitochondria are important in regulation of 
cell survival and the classic signs of cell death are preceded by mitochondrial alterations
6,7
. 
 
Mitochondrial impairment and defective oxidative phosphorylation have been linked to some human 
disorders
8,9,10
. Cartilage, due to the absence of vascularization, is living at 2–7% oxygen level, depending 
on the tissue depth. As a consequence, the activity of the mitochondrial respiratory chain (MRC) is low, 
compared to vascularized tissues, and most of the ATP molecules are coming from the glycolysis 
pathway
11,12
. However, recently we demonstrated that the analysis of MRC activity in OA cells showed a 
significant decrease in complex II and III activities compared to normal chondrocytes, as well as a 
reduction in mitochondrial membrane potential (Δψm)
13,14
. In this sense, different findings implicate a 
decreased mitochondrial bioenergetic reserve as a pathogenic factor in degenerative cartilage disease
15,16
. 
Based on these results, we postulated that TNFα and IL-1β could contribute to the mitochondrial 
alteration of chondrocytes and cartilage degradation. In this work, we demonstrate that the exposure of 
chondrocytes to TNFα and IL-1β modified mitochondrial function through a decrease in the activity of 
complex I of chain respiratory mitochondrial (CRM) and ATP production, as well as a reduction in Δψm. 
Besides, we show that the inhibition of complex I in human articular chondrocytes could play a key role 
in cartilage degradation modulated by TNFα and IL-1β. These data could be of value for a better 
understanding of the participation of TNFα and IL-1β in the pathogenesis of OA cartilage. 
  
Methods 
Chondrocyte cultures 
Normal human cartilage tissue (age 59 ± 22 years) was obtained at autopsy from 52 adults who had no 
history of joint disease (inflammatory arthritis, OA, microcrystalline arthritis and osteonecrosis). Under 
aseptic conditions, cartilage slices were removed from the condyles, minced and treated for 15 min with 
trypsin 0.5 mg/ml (Sigma Chemicals, St. Louis, MO, USA) after which the cartilage was removed from 
the trypsin and treated with 2 mg/ml clostridial collagenase (Sigma Chemicals) in Dulbecco's modified 
Eagle's medium (DMEM, Life Technologie, Paisley, UK), overnight at 37°C in an orbital shaker. The 
digest was centrifuged and the cells were resuspended in fetal calf serum (FCS)-enriched DMEM and 
cultured in flasks. Subcultures were performed with trypsin–ethylenediaminetetraacetic acid (EDTA) 
(Gibco) and first-passage cells were used. Cells were made quiescent by 48 h of incubation in the medium 
containing 0.5% FCS, washed and then stimulated with TNFα or IL-1β (R&D Systems, Abingdon, UK). 
This study was approved by the Ethics Committee of Galicia (Spain). 
Measurement of chondrocyte ATP levels 
To determine intracellular ATP levels, a luminescence ATP detection assay system based on the 
production of light caused by the reaction of ATP with added luciferase and d-luciferin was employed 
(ATP, Perkin Elmer, Barcelona, Spain). Briefly, chondrocytes were seeded at 2 × 10
4
 cells per well in 96-
well plates (Costar, Cambridge, MA, USA). After incubation for 72 h, 50 μl per well of mammalian cell 
lysis solution at room temperature was added and the plate was shaken for 5 min in an orbital shaker. 
Then 50 μl of substrate solution was added and the microplate was shaken for another 5 min. The plate 
was dark-adapted for 10 min; the emitted light was then measured by luminometry in a Micro Beta 
TriLux (Perkin Elmer). 
Measurement of the MRC complex activities in digitonin-permeabilized chondrocytes 
Chondrocytes (3.5 × 10
6
 per 140 mm tissue culture plate) were collected by trypsinization of cells, 
washed with phosphate buffered saline (PBS) and sedimented at 150g for 5 min at 4°C. The pellet was 
resuspended in 2 ml of ice-cold solution containing 20 mM 4-morpholinepropanesulphonic acid (MOPS), 
0.25 M sucrose and 200 μg of digitonin, per 5 × 106 cells. After 5 min of incubation on ice, the 
suspension was centrifuged at 5000g for 3 min at 4°C. The pellet was treated with 1.5 ml of 20 mM 
MOPS, 0.25 M sucrose and 1 mM EDTA buffer, incubated for 5 min and pelleted at 10,000g for 3 min at 
4°C. The pellet was resuspended in 200 μl, 10 mM phosphate buffer [potassium phosphate (KP), pH 7.4], 
frozen and thawed once and then mildly sonicated. These digitonin-permeabilized chondrocyte 
homogenates (10–50 μl per 1 ml of test volume) were used to measure the activities of the respiratory 
chain enzymes and citrate synthase (CS) in a DU-650 spectrophotometer (Beckman Instruments, Palo 
Alto, CA, USA). Incubation temperatures were 30°C for rotenone-sensitive NADH-coenzyme Q1 
reductase (complex I), SDH (complex II), antimycin-sensitive ubiquinol cytochrome c reductase 
(complex III), and CS, and 38°C for cytochrome c oxidase (complex IV). 
 
To correct for mitochondrial volume, enzyme activities were normalized to the specific activity of 
CS
17
. Briefly, complex I was measured by following the oxidation of NADH at 340 nm in 20 mM KP (pH 
8.0), 200 μM NADH, 1 mM NaN3, 0.1% bovine serum albumin (BSA)–EDTA, and 100 μM ubiquinone-
1 (Sigma Chemicals), in the absence of rotenone (Calbiochem, La Jolla, CA, USA) and then in the 
presence of 5 μM rotenone so that a rotenone-sensitive rate of NADH oxidation could be calculated. 
Complex II (SDH) was assessed by following the reduction of 2,6-dichlorophenolindophenol (DCPIP) 
(Sigma Chemical) at 600 nm in 50 mM Tris–KP (pH 7.0), 1.5 mM potassium cyanide (KCN) 100 μM 
DCPIP, and 32 mM succinate (Sigma Chemical). Complex III was assayed by measuring the reduction of 
cytochrome c at 550 nm in 50 mM KP (pH 7.5), 2 mM NaN3, 0.1% BSA–EDTA, 50 μM cytochrome c 
(Roche, Barcelona, Spain) and 50 μM decyl-ubiquinol (Sigma Chemical) in the absence of antimycin A 
(Sigma Chemical) and then in the presence of 0.01 mg/ml antimycin A, so that an antimycin A-sensitive 
rate of cytochrome c reduction could be calculated. Complex IV was measured by following the oxidation 
of reduced cytochrome c at 550 nm in 10 mM KP (pH 7.0) and 80 μM reduced cytochrome (freshly 
prepared before each experiment by adding sodium dithionite (Sigma Chemical)). CS was evaluated at 
420 nm in 75 mM Tris–HCl (pH 8), 100 μM 5,5′-dithiobis-(2-nitrobenzoic) acid (Sigma Chemical), 
350 μg/ml acetyl-coenzyme A (Sigma Chemical), 0.5 mM oxaloacetate (Roche), and 0.1% Triton X-100 
(Sigma Chemical). 
Determination of mitochondrial membrane potential (Δψm) 
To measure the Δψm of chondrocytes, DePsipher (R&D) a lipophilic cation (5, 5′, 6, 6′-tetrachloro-1, 
1′, 3, 3′-tetraethylbenzimidazolyl carbocyanine iodide) was used. DePsipher exists as a monomer at low 
values of Δψm (green fluorescence) and forms aggregates at a high Δψm (red fluorescence). Thus, 
mitochondria with a normal Δψm concentrate DePsipher into aggregates (red fluorescence), but with a de-
energized or depolarized Δψm, DePsipher forms monomers (green fluorescence). Briefly, chondrocytes 
(5 × 10
5
 cells per well in 6-well plate) were first made quiescent by incubation for 48 h in DMEM with 
0.5% FCS, after which basal cells and cells treated with the different stimuli were incubated for 12 h in 
serum-free medium. As positive control for depolarization valinomycin 1 μM was employed. The 
chondrocytes, which were collected by trypsinization, were then incubated with 1 μl/ml DePsipher for 
20 min at 37°C in a 5% CO2 incubator, sedimented, washed in PBS and analyzed by flow cytometry 
using FACScan and Cell-Quest software (Becton Dickinson, Mountain View, CA, USA). The analyzer 
threshold was adjusted on the forward light scatter (FSC) channel to exclude most of the subcellular 
debris. Photomultiplier settings were adjusted to detect DePsipher monomer fluorescence signals on the 
FL1 detector (green fluorescence, centered at ∼390 nm) and DePsipher aggregate fluorescence signals on 
the FL2 detector (red fluorescence, centered at ∼340 nm). Data analyses were performed with Paint-a-
Gate Pro Software (Becton Dickinson). Mean fluorescence intensity values for FL1 and FL2, expressed 
as relative linear fluorescence channels (arbitrary units scaled from channels 0 to 10,000) were obtained 
for all experiments. In each experiment, at least 20,000 events were analyzed. 
RNA isolation and ribonuclease protection analysis 
Total RNA was extracted from chondrocytes (3.5 × 10
6
 per 140 mm tissue culture plate) by the 
guanidine isothiocyanate–phenol–chloroform method. The concentration and purity of the RNA samples 
were determined by spectrophotometry. The probe preparation for the ribonuclease protection assay was 
carried out according to the instructions of the manufacturer (BD Pharmingen, Heidelberg, Germany). 
Briefly, single-strand antisense RNA probes, labeled with α [32P]-CTP (Amersham, Çbuckinghamshire, 
UK) were synthesized from linearized plasmids using T7 RNA polymerase (BD Pharmingen). 
Approximately 10
6
 cpm of probes were hybridized overnight at 56°C with 10–12 μg of total RNA in 
10 μl of hybridization buffer. Unhybridized RNA was digested for 45 min at 30°C in 100 μl RNAse 
solution. Then, 18 μl of proteinase K cocktail was added to each sample and incubated for 15 min at 37°C 
to remove the nucleases. The mixture was extracted with phenol/chloroform/isoamyl alcohol and 
precipitated with ethanol. The protected fragments were analyzed on a 6% TBE–Urea gel (Invitrogen, 
Paisley, Scotland, UK) and by subsequent autoradiography with X-OMAT AR film (Eastman Kodak, 
Rochester, NY, USA) with different exposition times form Bcl-2 mRNA and L-32. To quantify the 
relative amounts of mRNA of Bcl-2, the protected RNA fragments were scanned by bidimensional laser 
densitometry (Amersham). The data were standardized to the housekeeping gene L-32 (ribosomal protein 
p32) and the results are expressed as the percentage of basal gene expression as arbitrary densitometric 
units. 
  
Western-blot 
After stimulation cells (2.5 × 10
6
 per 100 mm tissue culture plate) were washed in ice-cold PBS, pH 
7.5, and lysed in 0.2 M Tris–HCl, pH 6.8 containing 2% SDS, 20% glycerol, 1 μg/ml cocktail inhibitor, 
and 1 mM phenyl methyl sulfonyl fluoride (PMSF) (Sigma Chemical). Samples were boiled for 5 min 
and protein concentrations were determined using a BCA reagent assay (Pierce Chemical Co., Rockford, 
IL, USA). Thirty micrograms of the protein extract was resolved on 12.5% sodium dodecyl sulfate 
(SDS)-polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Immobilon P, 
Millipore Co., Bedford, MA, USA). Membranes were first blocked in Tris buffered saline (TBS), pH 7.4 
containing 0.1% Tween-20, and 5% nonfat dried milk for 60 min at room temperature and then incubated 
overnight with anti-Bcl-2 (mouse anti-human Bcl-2, 1:2000, R&D, Abingdon, UK) or anti-Mcl-1 (mouse 
anti-human Mcl-1, 1:500, Oncogene) in fresh blocking solution at 4°C. After washing, the membranes 
were incubated with peroxidase conjugated secondary antibodies and developed using an ECL 
chemiluminescence kit (Amersham). In order to assure that equal amounts of total proteins were charged, 
we also hybridized each membrane with anti α-tubuline (Sigma Chemical). 
Cell viability 
Cell viability (12,000 cells per well in a 96-well plate) was evaluated using a colorimetric assay based 
on the MTT assay (Roche Diagnostics, Mannheim, Germany). For the colorimetric MTT assay, 10 μl 
MTT, a soluble tetrazolium salt solution (5 mg/ml in PBS), was added to the wells containing 100 μl 
medium and the plate was incubated for an additional 4 h. Thereafter, 100 μl of a solubilization solution 
(10% SDS in 0.01 M HCl) was added to dissolve the water-insoluble formazan salt. Quantification of 
apoptosis was then conducted with an enzyme-linked immunosorbent assay (ELISA) reader at 570 nm 
(Amersham). Both pools of cells, floating and attached chondrocytes, were employed in these 
experiments as well as in the experiments to analyze apoptosis. 
Histologic study 
Explants were made with a biopsy punch of 4 mm of diameter, and then they were placed in complete 
medium and were then incubated for 48 h with rotenone (50 μg/ml). Finally, tissues were fixed in 10% 
neutral buffered formalin, dehydrated and embedded in paraffin according to a standardized protocol. 
Sections (6 μm) were placed on SuperFrost Plus slides (Menzel-Glaser, Germany), deparaffinized in 
xylol, hydrated in a graded series of ethanol, and stained with hematoxylin–eosin or safranin O. Sections 
were visualized under Olympus BX61 Microscopy. 
Glycosaminoglycan assay 
Five explants of cartilage, which were made with biopsy punch of 4 mm of diameter, were cultured 
for up to 12 days in a 24-well plate with medium alone or with rotenone (50 μg/ml). Every 4 days 
medium was replaced and new stimuli were added. At day 12 supernatant was recovered and stored at 
−20°C until further analyzed. The release of proteoglycan was determined in conditioned cultured media 
as sulfated glycosaminoglycan (GAG) according to the instructions of the manufacturer (Biocolor, 
Newtownabbey, Northern Ireland). Briefly, reaction between GAG and dye, at acid pH, produces a dye–
GAG complex that results in the immediate formation of turbidity, quickly followed by precipitation of 
the dye–GAG complex within 10 min. Then, GAG-bound dye is recovered to add to each tube 1 ml of 
dissociation reagent. Finally, the GAG content of the assayed samples is determined by the amount of dye 
that is recovered from the sulfated GAGs in the test sample that is measured by absorbance to 656 nm and 
was expressed as ng GAG/mg weight of cartilage. 
  
Statistical analyses 
The data are expressed as the mean ± s.e.m. from determinations (n) or as representative results, as 
indicated. Individual donors were studied in duplicate or triplicate; cells from different donors were not 
pooled in any experiment. The statistical software program, SPSS (version 10.0, SPSS, Chicago, IL, 
USA) was used to perform the analysis of variance (ANOVA) or Tukey test. Differences were considered 
to be statistically significant at P < 0.05. 
Results 
Effect of cytokines on mitochondria 
The first set of experiments was focused on studying the effects of both pro-inflammatory cytokines 
(TNFα and IL-1β) on mitochondrial function by analyzing the activities of the respiratory chain enzyme 
complexes (I–IV) and CS, ATP synthesis and determining the Δψm. As shown in Table I when 
chondrocytes are exposed to TNFα (10 ng/ml) and IL-1β (5 ng/ml) for 48 h, the activity of complex I was 
significantly decreased when compared to basal cells (IL-1β = 18.3 ± 2.2 and TNFα = 18.4 ± 2.0 vs 
basal = 28.3 ± 2.4, P < 0.01). These reductions represent 35% of the total activity of complex I in basal 
condition. The mean values for complex II and IV in TNFα and IL-1β stimulated chondrocytes were 
lower than that in basal cells, but the differences were not statistically significant. The activities of 
complex III and CS were similar in the three groups. Furthermore, stimulation of cells with both IL-1β 
(5 ng/ml) and TNFα (10 ng/ml) for 72 h decreased significantly the synthesis of ATP by 19% and 18%, 
respectively (Table I). 
Table I. Modulation of mitochondrial activity induced by TNFα and IL-1β on human chondrocytic cells 
 
Control (n = 17) TNFα (n = 10) IL-1β (n = 12) 
    
CS enzymatic activity, (nmoles/min/mg protein) 117.8 ± 14.3 125.8 ± 12.9 122.1 ± 8.8 
MRC activity‡ 
Complex I 28.3 ± 2,4 18.4 ± 2.0* 18.3 ± 2.2* 
Complex II 10.8 ± 1.9 6.9 ± 0.9 6.6 ± 0.9 
Complex III 56.0 ± 3.6 58.0 ± 7.7 55.9 ± 4,5 
Complex IV 51.2 ± 5.3 49.1 ± 4.5 40.9 ± 5.0 
ATP (10−6 M) 1.71 ± 0.06 1.41 ± 0.06** 1.39 ± 0.07** 
    
 
Confluent chondrocytic cells were incubated for 48 h in basal conditions or in the presence of TNFα (10 ng/ml) or IL-1β (5 ng/ml). 
MRC complex activities were measured in digitonin-permeabilized chondrocytes as reported in Methods. Values are the 
mean ± s.e.m. CS = citrate synthase. ‡CS-corrected complex activity is expressed as (nmoles/min/mg protein)/(CS specific 
activity) × 100. Complex I = rotenone-sensitive NADH-coenzyme Q1 reductase; Complex II = succinate dehydrogenase; Complex 
III = antimycin-sensitive ubiquinol cytochrome c reductase; and Complex IV = cytochrome c oxidase. *P ≤ 0.01 of stimulated cells 
vs unstimulated chondrocytes. **P ≤ 0.05. 
 
 
  
To assess the effect of TNFα and IL-1β on the Δψm of chondrocytes, the fluorescent probe DePsipher 
was used. The staining pattern of DePsipher for basal chondrocytes was established as the standard. The 
total cell population could be divided into two subsets: one with an alteration of the Δψm (green 
fluorescence) and the other with normal Δψm (red fluorescence) [Fig. 1(A)]. Both TNFα (10 ng/ml) and 
IL-1β (5 ng/ml) caused a definitive decrease in the red/green fluorescence ratio in chondrocytes, 
indicating depolarization of the mitochondria [Fig. 1(B)]. These results were the consequence of a marked 
reduction in the percentage of cells with normal mitochondrial polarization (basal = 59 ± 4.6%; IL-
1β = 36 ± 5.7%; and TNFα = 40.9 ± 6.9%) and by an increased number of cells with mitochondrial 
depolarization (basal = 7.2 ± 1.8%; IL-1β = 16.8 ± 2.3%; and TNFα = 14.1 ± 3.0%) [Fig. 1(A)]. The 
mitochondrial depolarization was seen as early as 6 h, peaked at 12 h and was sustained at the highest 
levels at 24 h [Fig. 1(C)]. 
 
As Bcl-2 family proteins constitute a major point control on mitochondria activity, we studied the 
modulation of Bcl-2 expression by these cytokines. The analysis of the effect of both cytokines on the 
Bcl-2 family showed mRNA expression and protein synthesis induction. Both TNFα and IL-1β elicited 
the mRNA expression of the Bfl-1, Bid, Mcl-1 and Bax genes in a time- and dose-dependent manner (Fig. 
2). When Bcl-2 protein was evaluated, the results showed that it was induced by TNFα and IL-1β in a 
time-dependent manner [Fig. 3(A)]. A significant (P < 0.05) effect was detected at 36 h and it increased 
at 144 h. However, Mcl-1 significantly increased at 6 h and 36 h [Fig. 3(B)]. 
 
  
 
 
 
Fig. 1. Mitochondrial membrane depolarization induced by TNFα and IL-1β in human chondrocytes. (A) A representative density 
plot for each condition at 12 h is shown. The numbers represent the percentage of each population. (B) Histograms represent 
DePsipher fluorescence of normal and TNFα and IL-1β stimulated chondrocytes at 12 h. Relative to basal conditions, the green 
fluorescence (thick line) increases while red fluorescence (thin line) decreases in TNFα or IL-1β stimulated chondrocytes. The 
numbers represent the red/green fluorescence ratio values of eight different experiments, each performed in duplicate 
(mean ± s.e.m.) (P < 0.05 vs control). (C) Confluent human chondrocytes were incubated for the indicated times in medium alone or 
with TNFα (10 ng/ml) or IL-1β (5 ng/ml) before cells were analyzed by flow cytometry to quantify the mitochondrial membrane 
potential using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolyl carbocyanine iodide (DePsipher). Data acquisition was 
performed in a FACScan flow cytometer as detailed in Methods. Valinomycin (1 μM) was employed as a positive control for 
depolarization.  
 
 
 
Fig. 2. Time course and dose–response of Bcl-2 family mRNA expression by TNFα and IL-1β in human chondrocytes. Confluent 
chondrocytes were incubated for the indicated time intervals (6 h, 12 h and 48 h) (A), either in basal conditions or in the presence of 
TNF (10 ng/ml) or IL-1 (5 ng/ml). Chondrocytes were incubated for 48 h with DMEM alone or with increasing concentrations of 
TNFα (0.1, 1, and 10) (B) or IL-1β (0.05, 0.5, 5 and 12.5 ng/ml) (C). At the end of the incubation, total RNA was isolated and Bcl-2 
family mRNA expression was analyzed by the ribonuclease protection assay as reported in Methods. These blots are representatives 
of a total of three experiments. 
  
 
 
 
Fig. 3. Time course of Bcl-2 and Mcl-1 protein synthesis by TNFα and IL-1β on human chondrocytes. (A) Confluent chondrocytes 
were incubated for the indicated time intervals (6 h, 36 h and 144 h) either in basal conditions or in the presence of TNFα (10 ng/ml) 
or IL-1β (5 ng/ml). Bcl-2 protein was analyzed by Western-blot with rabbit anti-human Bcl-2. One representative blot from three 
experiments is shown. (B) Confluent chondrocytes were incubated for the indicated time intervals (6 h and 36 h), either in basal 
conditions or in the presence of TNFα (10 ng/ml) or IL-1β (5 ng/ml). The Mcl-1 protein was analyzed by Western-blot with rabbit 
anti-human Mcl-1. One representative blot from three experiments is shown. 
Inhibition of complex I activity reproduces the effect of TNFα and IL-1β 
To explain the functional significance of the inhibition of complex I activity by TNFα and IL-1β, 
several experiments with rotenone, a mitochondrial complex I inhibitor, were conducted. The distribution 
of the fluorescence in the population of chondrocytes demonstrated that rotenone reduced the cell 
population with red fluorescence (basal = 50.7 ± 3.9; rotenone = 45.0 ± 3.1) [Fig. 4(A)]. Rotenone caused 
a significant reduction of the red/green ratio (basal = 3 ± 0.2; rotenone = 1.8 ± 0.13) [Fig. 4(B)]. The 
study at the molecular level of the effects of rotenone showed that it also increased Bid, Bfl-1 and Mcl-1 
mRNA expression, as well as Bcl-2 protein synthesis [Fig. 4(C and D)]. 
 
 
  
 
 
 
Fig. 4. Rotenone-induced membrane depolarization and Bcl-2 expression in human chondrocytes. (A) Confluent human 
chondrocytes were incubated for 12 h in medium alone or with rotenone (50 μg/ml) before cells were analyzed by flow cytometry to 
quantify the mitochondrial membrane potential using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolyl carbocyanine iodide 
(DePsipher). The numbers represent the percentage of each population. (B) Histograms represent the DePsipher fluorescence of 
normal and rotenone-stimulated chondrocytes. Relative to the basal conditions, green fluorescence (thick line) increases while red 
fluorescence (thin line) decreases in rotenone-stimulated chondrocytes. The numbers represent the red/green fluorescence ratio 
values of eight different experiments, each performed in duplicate (mean ± s.e.m.) (P < 0.05 vs control). For Bcl-2 mRNA 
expression (C), chondrocytes were incubated for 6 h with DMEM alone or with rotenone (50 μg/ml). At the end of the incubation, 
total RNA was isolated and processed as described in Methods. This blot is representative of a total of three experiments. (D) 
Chondrocytes were incubated for the indicated time in medium alone or in the presence of 50 μg/ml rotenone. The whole cell lysate 
was obtained as described in Methods, and Bcl-2 protein was determined by immunoblot analyses. Tubuline levels were used to 
confirm the equal loading of samples. This blot is representative of a total of three experiments. 
  
Inhibition of complex I by TNFα and IL-1β is involved in the loss of ECM induced by these cytokines 
Both, TNFα and IL-1β are able to reduce proteoglycan synthesis and to induce loss of proteoglycan 
which leads to matrix breakdown18, 19. Thus, we assayed whether inhibition of complex I activity could 
mediate the effects of both TNFα and IL-1β on the loss of extracellular matrix (ECM) induced by 
cytokines. Rotenone reduced the proteoglycan content of the ECM in the superficial and middle zones, as 
shown by safranin O staining in the Fig. 5(B). Quantification of proteoglycans after cartilage stimulation 
with rotenone showed higher levels of GAG in supernatant compared with no stimulation cartilage [Fig. 
5(C)]. 
 
 
 
Fig. 5. Effect of rotenone on the ECM of human cartilage punches. Cartilage punches were incubated for 48 h in (A) medium alone 
and (B) rotenone (50 μg/ml). Tissues were stained with safranin O to detect proteoglycans in the ECM. A picture shows that 
rotenone induces a loss of stain in the superficial and middle zones of the cartilage. (C) Effect of rotenone on GAG's release. Human 
articular cartilage explants were incubated for 12 days in medium alone or with rotenone (50 μg/ml). At the indicated times GAGs 
were measured from the supernatants as described under Methods. Data are expressed as ng/mg protein, and represent the 
mean ± s.e.m. of five independent experiments by duplicate (*P ≤ 0.05 vs control). 
  
Finally, mitochondria play an important role in apoptosis; both the inhibition of complex I activity and 
the modification of Δψm are related to the apoptosis process. For this reason, we analyzed the effects of 
rotenone and both cytokines on cell viability by MTT assay. The results showed that neither stimuli were 
able to induce cellular death at any concentration and time studied [Fig. 6(A)]. Morphologic studies by 4′, 
6-diamidino-2-phenylindole dihydrochloride (DAPI) did not show any cellular change characteristic of 
apoptosis [Fig. 6(B)]. Additional experiments analyzing apoptosis by flow cytometry (DNA content in 
propidium iodide stained cells) and by ELISA (DNA fragmentation) confirmed these results (data not 
shown). 
 
 
 
Fig. 6. TNFα, IL-1β and rotenone do not induce cell death in human chondrocytes. (A) Human chondrocytes were incubated in 96-
well plates in basal conditions or with TNFα (10 ng/ml) or IL-1β (5 ng/ml) or rotenone (50 μg/ml). At 48 h cell viability was 
evaluated in both floating and attached cells using a colorimetric analyze based on the MTT assay. Data are expressed as 
percentages with respect to control conditions, and represent the mean ± SE of six independent experiments in triplicate. (B) 
Fluorescent micrographs are from DAPI untreated cells, and cells treated for 36 h with TNFα (10 ng/ml) or with IL-1β (5 ng/ml) or 
rotenone (50 μg/ml). All conditions show the normal morphology of chondrocyte nucleus. 
  
Discussion 
Recently, we demonstrated that the analysis of MRC activity in OA chondrocytes showed a 
significant decrease in complex II and III activities compared to normal chondrocytes, as well as a 
reduction in mitochondrial membrane potential (Δψm)
13
. TNFα and IL-1β are particularly important in the 
pathophysiology of joint disease. However, the precise contribution of TNFα and IL-1β in mitochondrial 
alteration of chondrocytes and cartilage degradation remains unknown. This is the first study 
documenting the effect of both pro-inflammatory cytokines, TNFα and IL-1β, on the activities of the 
MRC complexes (complex I–IV) and CS, and also on the Δψm in cultured human normal chondrocytes 
with possible implications for OA. 
 
After chondrocytes stimulation with TNFα and IL-1β, activity of complex I was decreased in a 35% 
vs total activity of complex I (rotenone-sensitive NADH-coenzyme) in basal condition. We measured 
respiratory chain complexes normalized to CS activity, because this enzyme is considered to be a marker 
of mitochondrial mass
20,21
. Therefore, the ratio of the specific respiratory complex/CS activity indicates 
whether differences in complex activities are due to the enrichment in mitochondrial proteins or result 
from a change in mitochondrial metabolic function. These results are in agreement with other reported 
observations showing that MRC complex I was inhibited by TNFα in Myelogenous leukemia cell line22. 
Similarly, TNFα and IL-1β exposure of the cardiomyocytes resulted in a selective oxygen consumption of 
the respiratory chain complexes I and II decreased by up to 45%
23
. 
 
These results differ from those that reported OA chondrocytes show a significant reduction in the 
activities of complexes II and III
13
. However, examination in more detail of those results showed a quasi 
significant reduction in the activity of complex I (P = 0.06). At the same time, the results reported here 
also show an important numerical reduction in complex II activity with a trend to statistical significance 
(basal: 10.8 ± 1.9 vs IL-1: 6.6 ± 0.9 and TNF: 6.9 + 0.9). All these data suggest that both complex I and II 
activities could be reduced in OA chondrocytes and in normal chondrocytes stimulated with TNFα or IL-
1β, respectively. 
 
A possible explanation for the discrepancy with the data reported previously by us, is that TNFα 
induces a functional modification of complex I activity. This participation of complex I activity in TNF-
induced mitochondrial modification could be regulated by substrate availability rather than by a 
permanent modification of complex I proteins
22,24
. However, alterations of MRC activities reported by 
our group in OA are permanent and definitive because they were shown in chondrocytes after several 
weeks in culture. These permanent modifications can be performed by several mutagen molecules such as 
nitric oxide (NO) or reactive oxygen species (ROS) localized in the synovial fluid of OA joints at high 
concentrations
25,26
. Then it is possible that OA chondrocytes express permanent alteration of complex II 
and III caused by mutations of DNA, and both cytokines (TNFα and IL-1β) induce a functional and 
reversible modification in the complex I. The combination of both effects (permanent and functional 
alteration of mitochondrial complexes) could cause a stronger modification of mitochondrial activity. 
 
Inhibition of the MRC by rotenone, a specific inhibitor of complex I, has been widely used to study 
the role of the MRC in several biologic processes
20,24,27,28
. In this paper, to explain the functional 
significance of the inhibition of complex I activity by TNFα and IL-1β, several experiments with 
rotenone were conducted. Interestingly, rotenone reproduced several effects mediated by both cytokines. 
It decreased Δψm, increased the Bfl-1 and Mcl-1 mRNA expression and Bcl-2 protein synthesis. 
 
Furthermore, rotenone, as well as TNFα and IL-1β, caused depletion of GAGs in the ECM with a 
histologic pattern similar to described after cartilage stimulation with both cytokines. TNFα and IL-1β are 
catabolic cytokines involved in cartilage degradation. The involvement of IL-1β in cartilage degradation 
was established from studies showing that intra-articular administration of IL-1β in rabbit and mouse 
joints resulted in prolonged loss of proteoglycans from the cartilage
3,4,5,18
. In this sense, studies in OA 
animal models have also demonstrated chondroprotective effects of anticytokine therapy
18,29
. We have 
confirmed previous results showing that both cytokines in vitro caused a depletion of proteoglycans in the 
superficial and middle zones of human normal cartilage (data not shown). A possible explanation for the 
depletion of proteoglycans by both cytokines could be the reduction of cell viability. However, we have 
demonstrated that both cytokines, and also rotenone, in our experimental conditions, are not capable of 
inducing cell death in chondrocyte. 
 
Other mechanisms can explain the effect of both TNFα and IL-1β on the depletion of proteoglycans. 
Both cytokines are able to reduce proteoglycan synthesis. Biosynthesis of aggrecans requires ATP and 
nicotinamide adenine dinucleotide phosphate (reduced) (NADPH). Cytokines could induce a decrease of 
NADPH supply at the level of pentose phosphate pathway, which could in turn take a part in the down-
regulation of aggrecan synthesis
24
. Furthermore, cytokines induce matrix metalloproteinases (MMPs) 
activity, and increase the synthesis of NO or ROS. Inhibition of complex I with rotenone also reduced the 
proteoglycan content of the ECM in the superficial and middle zones and it increased the release of GAGs 
from cartilage to supernatant. Under physiological conditions, the MRC is one of the most important sites 
of ROS production
24,26
. In chondrocytes ROS are produced in the membrane NADPH-oxidase and in the 
MRC
30
. In other cell types, such as macrophages or astrocytes, two sites in the respiratory chain, complex 
I and complex III, have been suggested to be the major ROS source
31,32
. However, the inhibition of 
complex I by rotenone in human chondrocytes does not modify basal and IL-1-induced NO synthesis 
(data not shown) as it was reported in other cell types
33
. 
 
Finally, chondrocytes activated by cytokines produce ECM-degrading enzymes; this process is 
associated with proteoglycan depletion. It was reported that rotenone induced up-regulation of gene sets 
involved in mitochondrial chaperone activity, protein degradation (proteases), respiratory chain assembly 
and division
34
. Several mechanisms to explain the effect of rotenone on gene expression have been 
described. Rotenone impeded ascorbate biosynthesis, demonstrating a link between complex I activity 
and synthesis of a key cellular anti-oxidant. The reduction of ascorbate levels may result in markedly 
increases of oxidized proteins. Furthermore, the activity of the proteosome system degrading oxidized 
proteins was reduced intensely after treatment with rotenone
35,36
. However, the capacity of mitochondria 
to induce the synthesis of MMPs in human chondrocytes is actually unknown and represents an attractive 
mechanism currently under study in our laboratory. 
 
Cartilage is a tissue influenced by acting factors both in epiphyseal zone (deep zone) and synovial 
fluid or synovium (superficial zone). Several lines of experimentation suggest that provision of glucose 
and oxygen supplied from synovial fluid may be critical particularly for chondrocytes in deep zone
11,12
, 
and that an anaerobic glycolysis and lactate production are involved in respiratory metabolism of articular 
cartilage even in aerobic conditions
11,37
. In our case, chondrocytes from superficial and deep zones were 
kept in standard media with high glucose concentration (4.5 mM) and aerobic conditions that could lead 
to cells to obtain their energy predominantly from an anaerobic glycolysis. For this reason, it is likely that 
the effect of cytokines observed here, in cultures maintained in normal atmosphere, is even more crucial 
in vivo, where the mitochondrial activity is probably lower. 
 
Taken together, our results indicate that both cytokines, TNFα and IL-1β, modified mitochondrial 
function by a mechanism involving decrease in the activity of complex I of CRM and ATP production, as 
well as a reduction in Δψm in human chondrocyte cells. These data suggest that inhibition of complex I 
may play an important role in the cartilage degradation modulated by TNFα and IL-1β. The present data 
support the idea that development of complex I activators may represent a novel therapeutic approach for 
cartilage degradation diseases. These data also could be important for a better understanding of the 
participation of TNFα and IL-1β in the pathogenesis of inflammatory arthropathies. 
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